Danaher Corporation (LON:0R2B)
London · Delayed Price · Currency is GBP · Price in USD 193.95
-5.41 (-2.71%)
At close: Aug 1, 2025
CTI BioPharma Market Cap
Danaher has a market cap or net worth of 106.54 billion as of August 1, 2025. Its market cap has decreased by -25.54% in one year.
Market Cap
106.54B
Enterprise Value
118.32B
Revenue
17.51B
Ranking
n/a
PE Ratio
42.81
Stock Price
$193.95
Market Cap Chart
Since December 10, 1969, Danaher's market cap has increased from 207.76M to 106.54B, an increase of 51,180.96%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 106.54B | -19.55% |
| Dec 31, 2024 | 132.43B | -1.32% |
| Dec 29, 2023 | 134.20B | -16.31% |
| Dec 30, 2022 | 160.36B | -7.64% |
| Dec 31, 2021 | 173.63B | 50.22% |
| Dec 31, 2020 | 115.58B | 38.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.60B |
| GSK plc | 57.26B |
| Haleon | 32.31B |
| Smith & Nephew | 10.17B |
| ConvaTec Group | 4.77B |
| Hikma Pharmaceuticals | 4.33B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.96B |